Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04375761 · ClinicalTrials.gov registry record
COVID-19: Human Epidemiology and Response to SARS-CoV-2
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 5,599
- Enrollment target
NCT04375761 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 5,599 participants.
The verdict
NCT04375761 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 5,599 participants
- Enrollment target
Study Summary
The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness. But it can also be more severe and even lead to death. The purpose of this study is to: * Determine the prevalence of SARS-CoV-2 carrier status over time in children and parents * Determine the prevalence of antibody development over time in children and parents * Compare carrier status and antibody development for children with asthma and/or other atopic conditions (e.g. eczema) versus children without asthma and/or other atopic conditions * Investigate the presence of SARS-CoV-2 exposure in historical samples from enrolled participants
Interventions
- PROCEDURE Collection of Biological Samples
- PROCEDURE Symptom and Exposure Surveys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,599 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2021-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04375761
The ClinicalTrials.gov registry entry for NCT04375761 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,599 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collection of Biological Samples is the first listed.
NCT04375761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04375761 about?
NCT04375761 is a clinical study titled "COVID-19: Human Epidemiology and Response to SARS-CoV-2". The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness. But it can also be more severe and even lead to death. The purpose of this study is to: * Determine the prevalence of SARS-CoV-2 carrier status over time in childr...
What is the current status of trial NCT04375761?
This trial is currently completed. The enrollment target is 5,599 participants. The study started on 2020-05-01. Estimated completion is 2021-03-29.
What interventions are being tested in trial NCT04375761?
The interventions under investigation include: Collection of Biological Samples (PROCEDURE), Symptom and Exposure Surveys (PROCEDURE).
Who is sponsoring clinical trial NCT04375761?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.